Welcome to our dedicated page for Trulieve Cannabis SEC filings (Ticker: TCNNF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to decode Trulieve Cannabis Corp’s multi-state cannabis disclosures can feel like reading two regulatory playbooks at once—federal securities rules and state-by-state marijuana laws. Hidden in those pages are the cultivation expansion costs, license approvals, and cash-intensive retail build-outs that move TCNNF’s share price.
Our platform solves that challenge. Stock Titan’s AI reads every Trulieve SEC filing the moment it hits EDGAR, then delivers plain-English answers to questions investors actually ask: “What changed in Trulieve’s quarterly earnings report 10-Q filing?” or “Did any directors buy shares in the latest Trulieve insider trading Form 4 transactions?” Interactive summaries highlight revenue per dispensary, biological asset fair-value swings, and cash burn—no accounting degree required.
All filing types are here, updated in real time: the annual report 10-K simplified for cannabis metrics, 8-K material events explained when new Florida stores open, proxy statement executive compensation details, and Form 4 insider transactions in near real-time. Need to track compliance costs across states? Our AI tags the exact footnotes. Comparing quarter-over-quarter trends? Download side-by-side tables pre-built from each 10-Q.
Whether you’re monitoring Trulieve executive stock transactions Form 4, seeking a concise Trulieve earnings report filing analysis, or simply want Trulieve SEC filings explained simply, this page turns dense cannabis disclosures into actionable insights—faster than you can say “vertically integrated.”
Trulieve Cannabis Corp. announced it will redeem all of its outstanding 8% Notes due October 6, 2026 for cash. The redemption covers US$368,000,000 principal as of November 4, 2025, at a price of 100% of principal plus accrued and unpaid interest up to, but excluding, the redemption date.
The redemption date is December 5, 2025. Payments and note surrender will occur through Odyssey Trust Company under the existing Indenture. The notes currently trade on the Canadian Securities Exchange as “TRUL.NT.U” and will be delisted in conjunction with the redemption.
Reese Jan, identified as Chief Financial Officer and a director of Trulieve Cannabis Corp. (TRUL), filed an Initial Statement of Beneficial Ownership on Form 3 reporting no ownership of the issuer's common stock as of the 09/08/2025 event date. The filing references an Exhibit 24 Power of Attorney and is signed on behalf of the reporting person by Eric Powers as attorney-in-fact on 09/30/2025.
FAQ
What is the current stock price of Trulieve Cannabis (TCNNF)?
What is the market cap of Trulieve Cannabis (TCNNF)?
